Pfizer

Page 29 of 37

Freda Lewis-Hall of Pfizer and Toby Cosgrove of the Cleveland Clinic and Google Cloud at the 2019 Fortune Brainstorm Health conference in San Diego.
Tech

Data Sheet–Drug Discovery Shifting From Treatment to Cure

By Aaron Pressman and Adam Lashinsky
April 4, 2019
Viagra

Viagra Sales Are Down. Here’s Why Pfizer Maintains Its Market Lead Anyway

By
February 15, 2019
Pfizer Acquires Wyeth For $68 Billion

Pfizer’s Best-Selling Drug Is Actually a Vaccine—and Its Price Keeps Increasing

By
February 5, 2019
Prescription bottles.

Net Drug Prices Are Falling, Even as List Prices Increase

By
January 30, 2019
Midsection of mature male pharmacist holding prescription paper and medicine standing by drawer at store

Prescription Drug Companies Are Raising Prices on Older Medicines

By
January 18, 2019
Under Pressure For Trump, Pfizer Agrees To Lower Drug Prices

Pfizer Offers Early Retirement to U.S. Employees Ahead of Layoffs

By
October 17, 2018
Biotech IPO Allogene
Health

Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO

By
October 11, 2018
CNBC Events

Pfizer CEO Ian Read to Step Aside Next Year for Albert Bourla to Take the Reins

By
October 1, 2018
EpiPen shortage Walgreens Auvi-Q
Health

There’s Still a Big EpiPen Shortage—But Walgreens Will Start Selling a Competing Product

By
September 7, 2018
Children's Advil Cold medicine and dosage chart.
Health

Pfizer Recalls Children’s Advil Product After Its Measuring Cup Confused Milliliters With Teaspoons

By
August 28, 2018
FDA EpiPen generic
Health

The FDA Finally Approved an EpiPen Generic. But a Shortage Looms Ahead of the School Year

By
August 16, 2018
Novartis drug prices trump
Health

Drug Giant Novartis Is Temporarily Backing Off Price Increases Following Trump Pressure

By
July 19, 2018
US-POLITICS-TRUMP
Health

3 Key Lessons From Trump’s Drug Price Feud With Pfizer

By
July 11, 2018
pfizer-pill-trump

Trump Criticizes Pfizer for Raising Drug Prices

By
July 10, 2018
Alzheimers-dementia-brain-research
Health

Eli Lilly, AstraZeneca’s Alzheimer’s Drug Flop Is the Latest Disappointment in a Frustrating Disease

By
June 12, 2018

Most Popular